New Sweetener Sweelin: 3,500 Times Sweeter Than Sugar Without Insulin Spike
Amai Proteins Ltd., a biotechnology company, has introduced a novel sweetener known as sweelin, which is reported to be 3,500 times sweeter than sucrose by weight. This new sweetening agent is particularly notable for its lack of impact on glucose and insulin responses, making it a potential alternative for individuals with diabetes or those concerned about blood sugar levels. In a double-blind, randomized clinical trial funded by Amai, researchers found that sweelin produced a glucose response that was 31-fold lower than that of typical sugar, with an insulin response that was 81-fold lower. This study, published in the journal Food Chemistry, marks the first investigation into the metabolic effects of a sweet protein, which is derived from rare tropical fruits. The sweet protein, inspired by the serendipity berry from West and Central Africa, has been refined using artificial intelligence to create sweelin, which comes in a white powder form that dissolves easily in liquids. For example, less than 3 mg of sweelin is sufficient to sweeten a serving of iced tea. Additionally, it can withstand high heat, allowing it to replace up to 70 percent of sugar in some recipes. Earlier this year, the US Food and Drug Administration expressed no concerns regarding the safety of sweelin. Currently, it is available as a sugar substitute in the US, Singapore, and Israel. The clinical trial involved 19 participants whose blood glucose, insulin, and GLP-1 levels were monitored after consuming a beverage containing sweelin. Participants repeated the trial with beverages sweetened by stevia and dextrose, a common sugar. The results indicated that sweelin's performance was comparable to stevia, producing significantly lower glucose and insulin responses than dextrose. Importantly, sweelin did not trigger a rise in GLP-1 levels, which is a hormone that typically increases after meals and is relevant for individuals with type 2 diabetes or obesity. While the initial findings are promising, the small sample size and duration of the study mean that further research is necessary to understand the long-term health effects of sweelin on a broader population. Until more extensive trials are conducted, the impact of this new sweetener on metabolic health remains uncertain. Nonetheless, the researchers conclude that sweelin could serve as a metabolically neutral sugar alternative, potentially aiding consumers in reducing added sugars in their diets.




